LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
195,900
-1,800 (-0.91%)
May 14, 2026, 3:30 PM KST
Market Cap7.22T +90.2%
Revenue (ttm)141.55B +12.4%
Net Income-74.28B
EPS-2,042.00
Shares Out36.85M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume528,739
Average Volume399,692
Open199,500
Previous Close197,700
Day's Range193,100 - 210,000
52-Week Range95,200 - 225,000
Beta0.50
RSI52.46
Earnings DateMay 15, 2026

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements